Daclizumab Subcutaneous and Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
Determining the interaction of Daclizumab Subcutaneous and Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: amlodipine / hydrochlorothiazide / olmesartan
Brand name: Tribenzor
Synonyms: Amlodipine, hydrochlorothiazide, and olmesartan, Olmesartan, Amlodipine, and Hydrochlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Olmesartan, Amlodipine, and Hydrochlorothiazide
- Daclizumab Subcutaneous-Olodaterol
- Daclizumab Subcutaneous-Olodaterol and tiotropium
- Daclizumab Subcutaneous-Olodaterol Hydrochloride
- Daclizumab Subcutaneous-Olodaterol inhalation
- Daclizumab Subcutaneous-Olopatadine nasal
- Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide-Dacogen
- Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide-Dacomitinib
- Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide-Dactinomycin
- Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide-Dactinomycin Injection
- Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide-Dactinomycin Intravenous
- Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide-Daklinza